(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 2.97% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Envista Holdings's revenue in 2025 is $2,503,900,000.On average, 7 Wall Street analysts forecast NVST's revenue for 2025 to be $431,715,963,617, with the lowest NVST revenue forecast at $425,790,189,182, and the highest NVST revenue forecast at $439,174,748,086. On average, 7 Wall Street analysts forecast NVST's revenue for 2026 to be $447,110,130,034, with the lowest NVST revenue forecast at $440,539,965,975, and the highest NVST revenue forecast at $453,259,118,866.
In 2027, NVST is forecast to generate $463,528,506,471 in revenue, with the lowest revenue forecast at $453,619,956,717 and the highest revenue forecast at $470,512,896,789.